ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Rhode Island » Internal Medicine

Top Internal Medicine Prescribers in Rhode Island

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JIBRAN KHAN M.D.

Internal Medicine

8,162

$420K

272
139 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

17%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $51

CATHLEEN WHELAN MD

Internal Medicine

8,140

$397K

248
230 are 65+

23%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $51

DONALD HEBB MD

Internal Medicine

8,118

$403K

384
329 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $51

AMBER GUL M.D.

Internal Medicine

8,094

$367K

380
304 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $51

STEVEN KEMPNER MD

Internal Medicine

8,057

$399K

345
287 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $51

GEORGE SEHL D.O.

Internal Medicine

8,012

$355K

181
177 are 65+

20%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $51

JOHN BARRETT D.O.

Internal Medicine

7,988

$372K

402
369 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $51

TODD VICCIONE MD

Internal Medicine

7,976

$520K

358
294 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$65
Average prescription price

Avg: $51

CLAUDE YOUNES M.D.

Internal Medicine

7,974

$599K

387
308 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 22%

$75
Average prescription price

Avg: $51

ROBERT COHEN M.D.

Internal Medicine

7,911

$368K

418
330 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $51

EDWARD STULIK MD

Internal Medicine

7,896

$313K

446
409 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 22%

$40
Average prescription price

Avg: $51

FADI MANSOURATI MD

Internal Medicine

7,877

$654K

267
210 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$83
Average prescription price

Avg: $51

BRUCE FISCHER MD

Internal Medicine

7,824

$300K

328
274 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$38
Average prescription price

Avg: $51

FRANK SAVORETTI MD

Internal Medicine

7,794

$248K

490
435 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 22%

$32
Average prescription price

Avg: $51

STEVEN MALLOZZI MD

Internal Medicine

7,745

$405K

452
394 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $51

KENNETH HATHAWAY D.O.

Internal Medicine

7,703

$305K

368
329 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$40
Average prescription price

Avg: $51

MARK PAULOS MD

Internal Medicine

7,674

$514K

440
400 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$67
Average prescription price

Avg: $51

JEFFREY BARON MD

Internal Medicine

7,668

$483K

302
278 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $51

SHELLY JOHNSON MD

Internal Medicine

7,663

$306K

412
350 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$40
Average prescription price

Avg: $51

JOHN MISKOVSKY MD

Internal Medicine

7,513

$595K

318
240 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$79
Average prescription price

Avg: $51

DANIEL VALICENTI MD

Internal Medicine

7,480

$419K

195
159 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

JOSEPH DOTOLO M.D.

Internal Medicine

7,463

$302K

277
258 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$40
Average prescription price

Avg: $51

DAVID MARCOUX M.D.

Internal Medicine

7,434

$400K

512
442 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $51

DAVID STEIGMAN MD

Internal Medicine

7,424

$352K

257
224 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $51

DAVID CUNNINGHAM MD

Internal Medicine

7,423

$385K

384
338 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $51

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank